{"schema_version":"secwatch.filing_event.v1","accession":"0001410098-26-000040","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2026-07-02T20:30:35+00:00","discovered_at":"2026-07-02T20:33:01.868835+00:00","generated_at":"2026-07-02T20:33:37.697503+00:00","sec_items":["8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CorMedix appoints Elizabeth Hurlburt as Chief Operating and Commercial Officer; Michael Seckler departs","bullets":["Elizabeth Hurlburt, previously COO, appointed to newly created role of Chief Operating and Commercial Officer, effective June 29, 2026.","Hurlburt will oversee commercial, medical affairs, regulatory, and clinical functions, reporting to Chairman & CEO Joseph Todisco.","Michael Seckler has left the Company as part of the leadership restructuring."],"urls":{"canonical":"https://secwatch.observer/filing/0001410098-26-000040","json":"https://secwatch.observer/filing/0001410098-26-000040.json","markdown":"https://secwatch.observer/filing/0001410098-26-000040.md","text":"https://secwatch.observer/filing/0001410098-26-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/0001410098-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000141009826000040/crmd-20260629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:33:37.697503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}